Apple cider vinegar (ACV) has been consumed for centuries as a traditional remedy and culinary ingredient. In recent years, apple cider vinegar powder has emerged as a practical alternative to liquid ACV, offering improved stability, portability, and formulation flexibility while preserving the key bioactive compounds of the original vinegar. This article reviews the scientific literature on apple cider vinegar powder, covering its production, composition, and documented research findings.

Production and Composition

Apple cider vinegar powder is produced by converting liquid ACV into a dry, free-flowing powder through advanced drying technologies. Spray drying and freeze-drying are the two primary methods used. Spray drying involves atomizing the liquid vinegar into a hot air stream, often with a carrier such as maltodextrin or gum arabic to encapsulate volatile organic acids and other bioactive compounds. Freeze drying, by contrast, freezes the vinegar and removes ice crystals via sublimation under vacuum, which can better preserve heat-sensitive components.

Research has optimized spray drying conditions to maximize the retention of bioactive components. A 2023 study found that carrier concentration—particularly gum arabic—was the main factor influencing powder properties, contributing to the retention of volatile and heat-sensitive compounds. The resulting powders demonstrated high solubility (exceeding 94%) and high antioxidant recovery. The study concluded that ACV-based functional powder is feasible for development as a dietary supplement.

The primary active component in apple cider vinegar powder is acetic acid, which is the compound most frequently investigated in clinical research. ACV also contains polyphenols and other organic acids that contribute to its overall composition. When selecting ACV powder products, attention should be paid to the acetic acid content and the carrier materials used, as these influence both the product's functional properties and its suitability for specific applications.

Glycemic and Lipid Parameters

A substantial body of clinical research has examined the relationship between ACV consumption and markers of glucose and lipid metabolism. A 2025 systematic review and meta-analysis of 25 clinical trials involving 1,320 adults found that ACV consumption was associated with significant reductions in fasting blood glucose (FBG) by 21.20 mg/dL, HbA1c by 0.91 mg/dL, and total cholesterol (TC) by 6.72 mg/dL. Subgroup analysis revealed that these effects were particularly pronounced in diabetic patients.

Another dose-response meta-analysis focusing on type 2 diabetes patients, published in 2025, similarly reported that ACV significantly reduced fasting blood sugar (WMD: -21.929 mg/dL) and HbA1c. These findings suggest that ACV may play a role in supporting glycemic management, particularly in populations with existing metabolic concerns.

The mechanisms underlying these effects are thought to involve acetic acid's ability to slow gastric emptying and reduce the rate of postprandial glucose rise. Acetic acid has also been shown to enhance fat oxidation, inhibit fat synthesis, and increase mitochondrial activity. In addition, ACV demonstrates antioxidant properties that may contribute to its overall effects.

Body Weight and Body Composition

The relationship between ACV and body weight has been the subject of multiple randomized controlled trials. A 2024 randomized, double-blind, placebo-controlled study published in BMJ Nutrition, Prevention & Health examined the effects of ACV on weight management in Lebanese adolescents and young adults with overweight and obesity. Participants consuming 5 mL, 10 mL, or 15 mL of ACV daily demonstrated significant decreases in body weight and BMI by week 12 compared to placebo. The effects appeared to be time-dependent, with the most pronounced changes observed at week 12. Notably, the three doses showed similar levels of efficacy, suggesting that the effects were not strongly dose-dependent.

A 2025 systematic review and meta-analysis of randomized controlled trials further assessed the effect of ACV on anthropometric measurements in adults with type 2 diabetes and/or overweight. The pooled analysis suggested that ACV supplementation may serve as a promising adjunctive strategy for short-term weight management in adults with excess body weight or metabolic complications.

Gut Microbiota and Digestive Health

Emerging research has begun to explore the relationship between apple cider vinegar powder and gut microbiota. A 2025 study published in Nutrients investigated whether apple cider vinegar powder (ACVP) alleviates high-fat-diet (HFD)-induced liver injury in mice by modulating the gut-liver axis. Over a 12-week period, mice receiving daily ACVP gavage while on a HFD showed attenuated weight gain by 26.3%, reduced hepatomegaly and dyslipidemia, and decreased serum ALT (48%) and AST (21.5%). ACVP also restored gut microbiota diversity, enriching beneficial bacterial groups. Metabolomic analysis identified 38 HFD-perturbed metabolites that were reversed by ACVP treatment. The study concluded that ACVP mitigates HFD-induced liver injury by remodeling gut microbiota, restoring microbial metabolites, and enhancing gut-liver crosstalk.

Another study examined the effect of apple vinegar powder on functional constipation in mice. Researchers found that ACVP intervention significantly shortened the time to first black stool excretion, increased fecal water content, and improved small intestine propulsion. ACVP treatment also increased serum levels of motilin, substance P, and serotonin while decreasing somatostatin and vasoactive intestinal peptide. Furthermore, ACVP increased the length of colon crypts and enhanced the alpha-diversity of gut microbiota. The study indicated that ACVP could improve defecation ability and gut microbiota diversity in constipated mice.

Antimicrobial Properties

Research has also evaluated the antimicrobial activity of apple cider vinegar. A 2025 study assessed the antibacterial properties of both liquid and powdered ACV against methicillin-resistant Staphylococcus aureus (MRSA). Undiluted liquid ACV produced a 7 mm inhibition zone, and the powdered form exhibited comparable inhibition zones at various dilutions. These findings support ACV's traditional use as a disinfectant and suggest that the powder form retains antimicrobial activity.

Applications and Considerations

Apple cider vinegar powder offers several practical advantages over liquid ACV. It is lightweight, compact, and has an extended shelf life of up to two years when stored properly. The powder form integrates seamlessly into various product formats, including drink mixes, capsules, gummies, and functional snacks. It can also be used in culinary applications such as dry rubs, seasonings, salad dressings, and baked goods.

When formulating with ACV powder, attention should be paid to the carrier materials used in production, as these can affect both the sensory profile and the functional properties of the final product. Products with clear labeling regarding acetic acid content and minimal additives are generally preferable for health-conscious applications.

Conclusion

Apple cider vinegar powder represents a science-backed functional ingredient with a growing body of research supporting its potential applications. Clinical evidence indicates associations with improvements in glycemic parameters, lipid profiles, and body weight management. Emerging animal studies suggest additional avenues of investigation in gut microbiota modulation and digestive health. As a stable, versatile powder form of traditional ACV, it offers formulation flexibility for dietary supplements, functional foods, and beverages. Further research, particularly well-controlled human trials using standardized ACV powder formulations, will continue to clarify its role in nutritional science.